Our mission

providing effective regenerative solutions for a sustainable healthcare

MyStem LLC is an emerging leader in regenerative medicine utilizing autologous Regenerative Fraction.

MyStem LLC’s proprietary single-use medical device is able to efficiently and reproducibly separate a Regenerative Fraction which natively contains progenitor cells from Stromal tissue surrounding soft tissue structures.

The myStem ® device is CE, ANVISA and TGA approved and the company continues to expand its activities globally.

MyStem LLC is continuously involved in scientific collaboration with surgeon leaders in regenerative medicine in order to progress product development efforts to advance the ease of use in delivering best care to patients globally.